Plain-English translation of NCT06385080 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new drug called to treat head and neck cancer that has returned or spread. Researchers want to see how well this medication works on its own, and also how it performs when combined with other cancer drugs like , , or . The study will also test whether the medication can help patients before and after surgery.
Head and neck cancers that return or spread to other parts of the body are very difficult to treat, and current options don't work for everyone. This trial exists to find out if this new treatment could give patients another option when standard therapies aren't enough or no longer work.
You likely qualify if…
You likely don't qualify if…
Depending on which part of the trial you join, you would receive as an injection under the skin, starting with weekly doses in the first month, then switching to every-three-weeks dosing. Some participants will receive the medication alone, while others will also receive additional cancer drugs intravenously (into a vein). You will have regular visits to the clinic for treatment, blood tests, and imaging scans to see how well the treatment is working and to monitor for side effects.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
United States